TOOsonix receives MDR CE Mark for its new oncology and dermatology device

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

PR Newswire associated2

PR Newswire associated3

Tags

TOOsonix

More Like This

PR Newswire associated0

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)

HistoSonics Edison Histotripsy System (Photo: Business Wire)

FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System

HistoSonics Awarded Key Position in UK’s Novel Innovation Program

HistoSonics Edison Histotripsy System (Photo: Business Wire)

World’s First Patients Treated With Novel Edison® Histotripsy System

Example of HistoSonics technology targeting kidney tissue to be destroyed in a non-invasive histotripsy procedure. (Photo: Business Wire)

World’s First Kidney Tumor Treated Using the HistoSonics’ Edison® Histotripsy System

PR Newswire associated0

Sirtex Medical Announces Certification of SIR-Spheres® Y-90 Resin Microspheres According to Medical Device Regulation (EU) 2017/745 and European Launch of the Innovative SIROS™ Delivery System

HistoSonics Edison® Histotripsy System (Photo: Business Wire)

HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform

PR Newswire associated0

Calyx Medical Imaging Supports Groundbreaking Melanoma Treatment Approval